Climb Bio
As of the edition of 20 October 2026, Climb Bio runs 3 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Family history
The records place 2 company names in this family.
Drugs by status
| Status | Count |
|---|---|
| Active | 2 |
| Status not established | 1 |
| Total | 3 |
Where its trials are
- Immune system: 3 trials led
- Blood and lymph: 1 trials led
- Pregnancy and women's health: 1 trials led